- Home
- NBY vs RDHL Comparison
NBY vs RDHL Comparison
Compare NBY & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- RDHL
- Stock Information
- Founded
- NBY 2000
- RDHL 2009
- Country
- NBY United States
- RDHL Israel
- Employees
- NBY N/A
- RDHL N/A
- Industry
- NBY
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- NBY
- RDHL Health Care
- Exchange
- NBY Nasdaq
- RDHL Nasdaq
- Market Cap
- NBY 3.4M
- RDHL 3.8M
- IPO Year
- NBY 2007
- RDHL N/A
- Fundamental
- Price
- NBY $0.58
- RDHL $1.99
- Analyst Decision
- NBY Strong Buy
- RDHL
- Analyst Count
- NBY 1
- RDHL 0
- Target Price
- NBY $0.85
- RDHL N/A
- AVG Volume (30 Days)
- NBY 41.7K
- RDHL 214.4K
- Earning Date
- NBY 05-15-2025
- RDHL 04-10-2025
- Dividend Yield
- NBY N/A
- RDHL N/A
- EPS Growth
- NBY N/A
- RDHL N/A
- EPS
- NBY 0.57
- RDHL N/A
- Revenue
- NBY $9,781,000.00
- RDHL $8,042,999.00
- Revenue This Year
- NBY $23.91
- RDHL $381.91
- Revenue Next Year
- NBY $32.05
- RDHL N/A
- P/E Ratio
- NBY $1.27
- RDHL N/A
- Revenue Growth
- NBY 20.52
- RDHL 23.17
- 52 Week Low
- NBY $0.36
- RDHL $1.71
- 52 Week High
- NBY $3.15
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- NBY 52.01
- RDHL 51.03
- Support Level
- NBY $0.55
- RDHL $1.82
- Resistance Level
- NBY $0.61
- RDHL $1.93
- Average True Range (ATR)
- NBY 0.02
- RDHL 0.08
- MACD
- NBY 0.00
- RDHL 0.04
- Stochastic Oscillator
- NBY 50.00
- RDHL 100.00
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.